摘要
目的:探讨平消胶囊对乳腺癌术后化疗骨髓抑制的减缓作用。方法:2006年3月-2009年3月我科对110例乳腺癌改良根治术后化疗患者,随机分为两组,均采用FEC方案化疗,治疗组58例,加用平消胶囊口服;对照组52例,单独化疗,不口服平消胶囊。结果:口服平消胶囊(西安正大制药有限公司生产)的患者化疗后第2周白细胞恢复至正常范围,而对照组白细胞第3周恢复至正常范围。结论:平消胶囊能有效减轻化疗对乳腺癌患者的骨髓抑制。
Objective：To investigate the role of capsule Pingxiao in reducing the bone marrow suppression for breast cancer patients with postoperative chemotherapy. Methods：All 110 cases of breast cancer after modified radical mastectomy with chemotherapy were randomly divided into two groups all patients were treated with FEe chemothera- py ,58 cases in treatment group, plus oral capsule Pingxiao,52 cases in controlv group, treated by chemotherapy alone. Results ：The white blood cells in patients of treatment group returned to normal range in the second week after chemo- therapy, while WBC of control group returned to normal range in the third week. Conclusion： Capsule Pingxiao can effectively reduce bone marrow suppression in breast cancer chemotherapy.
出处
《现代肿瘤医学》
CAS
2010年第5期908-909,共2页
Journal of Modern Oncology
关键词
平消胶囊
乳腺癌
化疗
骨髓抑制
capsule Pingxiao
breast cancer
chemotherapy
bone marrow suppression
